يعرض 381 - 400 نتائج من 21,342 نتيجة بحث عن '(( significant decrease decrease ) OR ( significant ((we decrease) OR (teer decrease)) ))*', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 381

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> حسب Razia Rashid Rahil (22772495)

    منشور في 2025
    "…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"
  2. 382

    Grade system. حسب Zhuoyang Xia (21354186)

    منشور في 2025
    الموضوعات:
  3. 383

    Literature search. حسب Zhuoyang Xia (21354186)

    منشور في 2025
    الموضوعات:
  4. 384

    Study characteristics. حسب Zhuoyang Xia (21354186)

    منشور في 2025
    الموضوعات:
  5. 385

    Flowchart of literature retrieval. حسب Zhuoyang Xia (21354186)

    منشور في 2025
    الموضوعات:
  6. 386

    Data extraction. حسب Zhuoyang Xia (21354186)

    منشور في 2025
    الموضوعات:
  7. 387
  8. 388
  9. 389
  10. 390

    Supplementary data. حسب Malte Ostendarp (13217973)

    منشور في 2025
    الموضوعات:
  11. 391

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  12. 392

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  13. 393
  14. 394
  15. 395

    Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. حسب Francesca Catto (21253435)

    منشور في 2025
    "…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …"
  16. 396
  17. 397
  18. 398
  19. 399
  20. 400